Dapsone
NDC 72300-188
Product Information
Dapsone is a ANDA-approved product labeled by Acrux Dds Pty Ltd. This medication is used to treat a certain type of skin disorder (dermatitis herpetiformis). It is supplied as a white product. This product entry covers the primary NDC 72300-188 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 72300-188?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DAPSONE (UNII: 8W5C518302)
- DAPSONE (UNII: 8W5C518302) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S) (UNII: 5F4963KLHS)
- ISOHEXADECANE (UNII: 918X1OUF1E)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1741905 - dapsone 7.5 % Topical Gel
- RxCUI: 1741905 - dapsone 0.075 MG/MG Topical Gel
* Please review the full disclaimer at the bottom of this page.